Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Clinical trial NCT05705492 · RECRUITING

Trial details

NCT number: NCT05705492
Sponsor: OHSU Knight Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Solid Neoplasm Advanced Biliary Tract Carcinoma Advanced Esophageal Carcinoma Metastatic Esophageal Carcinoma Locally Advanced Colorectal Carcinoma Locally Advanced Esophageal Carcinoma Locally Advanced Gastric Carcinoma Metastatic Colorectal Carcinoma (mCRC)Advanced Lung Carcinoma Locally Advanced Hepatocellular Carcinoma

Start date: 2024-07-17
Primary completion: 2027-06-30
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.